NO | Khoom | Cas tsis muaj | Daim ntawv thov | Qhov Tseem Ceeb Ntsuas | ||||
Kev coj dawb huv | Yog dab neeg | Kev ruam | * Max1 | Dej | ||||
1 | FMOC-CYS (ACM) -O | 86060-81-3 | Disulfide Bond | ≥99.0% | I≤0.1% | I≤0.1% | I≤0.2% | ≤1.0% |
2 | FMOC-CYS (MMT) -O | 177582-21-7 | Disulfide Bond | ≥98.0% | I≤0.2% | I≤0.3% | I≤0.5% | ≤1.0% |
3 | FMOC-CYS (4-ALLYLBUTHRATE) -O | / | Disulfide Bond | ≥98.0% | I≤0.2% | I≤0.3% | I≤0.5% | ≤1.0% |
4 | MPa (Trt) -o | 27144-18-9 | Kawg ntawm kev ua ntu zus | ≥99.5% | / | I≤0.1% | I≤0.2% | ≤1.0% |
5 | Fmoc-thr (tbu) -ol | 189337-28-8 | Octreotide | ≥97.0% | I≤0.3% | I≤0.5% | ≤1.0% | ≤1.0% |
6 | FMOC-D-Arg (PBF) -O | 187618-60-6 | Desmopressin | ≥99.0% | I≤0.2% | I≤0.3% | I≤0.3% | ≤2.0% |
7 | Fmoc-gly-gly-oh | 35665-38-4 | Balivalirudin | ≥99.5% | / | I≤0.1% | I≤0.2% | ≤1.0% |
8 | Fmoc-gly-gly-gly-oh | 170941-79-4 | Terlipressin | ≥99.5% | / | I≤0.1% | I≤0.2% | ≤1.0% |
9 | Fmoc-gly-gly-gly-gly-oh | / | Balivalirudin | ≥99.5% | / | I≤0.1% | I≤0.2% | ≤1.0% |
10 | Fmoc-gly-asp (tbu) -oh | / | Balivalirudin | ≥99.5% | / | I≤0.15% | I≤0.2% | ≤1.0% |
11 | BOC-CYS (TRT) -O | 21947-98-8 | Kawg ntawm kev ua ntu zus | ≥99.0% | I≤0.2% | I≤0.3% | I≤0.3% | ≤1.0% |
12 | Boc-arg (PBF) -oh | 200124-22-7 | Kawg ntawm kev ua ntu zus | ≥99.0% | I≤0.2% | I≤0.3% | I≤0.3% | ≤1.0% |
13 | Boc-ala-huag | 15761-38-3 | Kawg ntawm kev ua ntu zus | ≥99.0% | I≤0.2% | I≤0.3% | I≤0.3% | ≤1.0% |
14 | BOC-D-PE-Huag | 18942-49-9 | Kawg ntawm kev ua ntu zus | ≥99.0% | I≤0.2% | I≤0.3% | I≤0.3% | ≤1.0% |
15 | Boc-gly-oh | 4530-20-5 | Kawg ntawm kev ua ntu zus | ≥99.5% | / | I≤0.1% | I≤0.2% | ≤1.0% |
16 | Boc-lys (boc) -oh.dcha | 15098-69-8 | Kawg ntawm kev ua ntu zus | ≥99.0% | I≤0.2% | I≤0.3% | I≤0.3% | ≤1.0% |
17 | Boc-ser (tbu) -oh | 7738-22-9 | Kawg ntawm kev ua ntu zus | ≥99.0% | I≤0.2% | I≤0.3% | I≤0.3% | ≤1.0% |
18 | Boc-br (tbu) -oh | 13734-40-2 | Kawg ntawm kev ua ntu zus | ≥99.0% | I≤0.2% | I≤0.3% | I≤0.3% | ≤1.0% |
19 | Boc-d-ala-huag | 7764-95-6 | Kawg ntawm kev ua ntu zus | ≥99.0% | I≤0.2% | I≤0.3% | I≤0.3% | ≤1.0% |
20 | BOC-ntsib-AH | 2488-15-5-5 | Kawg ntawm kev ua ntu zus | ≥99.0% | I≤0.2% | I≤0.3% | I≤0.3% | ≤1.0% |
21 | Boc-Tyr (TBU) -O | 47375-34-8 | Kawg ntawm kev ua ntu zus | ≥99.0% | I≤0.2% | I≤0.3% | I≤0.3% | ≤1.0% |
22 | BOC-D-cam (PDF) -O | 187618-60-6 | Kawg ntawm kev ua ntu zus | ≥99.0% | I≤0.2% | I≤0.3% | I≤0.3% | ≤1.0% |
23 | Boc-asp (OTBU) -oh.dcha | 1913/12/8 | Kawg ntawm kev ua ntu zus | ≥99.0% | I≤0.2% | I≤0.3% | I≤0.3% | ≤1.0% |
24 | FMOC-Homoarg (PBF) -O | 1159680-21-3 | Eptifibatide | ≥98.5% | I≤0.2% | / | I≤0.5% | ≤2.0% |
25 | FMOC-ASP-OTBU | 129460-09-09-9 | Thymalfasin | ≥99.5% | I≤0.1% | I≤0.1% | I≤0.2% | ≤1.0% |
26 | FMOC-Tyr (Me) -H | 77128-72-4 | Carbetocin | ≥98.5% | I≤0.2% | I≤0.3% | I≤0.5% | ≤1.0% |
27 | FMOC-ONN (BOC) -O | 109425-5-5-0 | Nyob rau hauv Suavmwm Daptomycin | ≥99.5% | I≤0.1% | I≤0.1% | I≤0.2% | ≤2.0% |
28 | FMOC-D-Tyr (ET) -O | 162502-65-0 | Nyob rau hauv | ≥99.5% | I≤0.1% | I≤0.1% | I≤0.2% | ≤1.0% |
29 | FMOC-ASP (OALL) -OH | 146982-24-3 | Melanotan | ≥99.0% | I≤0.2% | I≤0.3% | I≤0.3% | ≤1.0% |
30 | AC-NLE-AH | 15891-49-3 | Melanotan | ≥99.0% | / | I≤0.3% | I≤0.3% | ≤1.0% |
31 | Fmoc-nle-oh | 77284-32-3 | Melanotan Afamelanotide | ≥99.0% | / | I≤0.3% | I≤0.3% | ≤1.0% |
32 | AC-GLU (OTBU) -O | 84192-88-1 | Tus sib cav Acetyl Octapeptide-3 | ≥99.0% | I≤0.2% | I≤0.3% | I≤0.3% | ≤1.0% |
33 | AC-β-ala-edi-· Dchas | / | Acetyl Tetrapeptide-5 | ≥99.0% | / | I≤0.3% | I≤0.3% | ≤1.0% |
34 | FMOC-ß-ala-huag | 35737-10-1 | Acetyl Tetrapeptide-5 | ≥99.5% | / | I≤0.1% | I≤0.2% | ≤1.0% |
35 | Fmoc-hyp (tbu) -oh | 122996-47-8 | Tus kab ntxwv hauv Icatibant | ≥98.0% | I≤0.2% | I≤0.3% | I≤0.5% | ≤1.0% |
36 | FMOC-THI-AH | 130309-35-2 | Tus kab ntxwv hauv Icatibant | ≥98.0% | I≤0.2% | I≤0.3% | I≤0.5% | ≤1.0% |
37 | FMOC-D-TIC-AH | 130309-33-0 | Tus kab ntxwv hauv Icatibant | ≥98.0% | I≤0.2% | I≤0.3% | I≤0.5% | ≤1.0% |
38 | Fmoc-oic-oh | 130309-37-4 | Tus kab ntxwv hauv Icatibant | ≥98.0% | I≤0.2% | I≤0.3% | I≤0.5% | ≤1.0% |
39 | Boc-sar-huag | 13734-36-6 | Saralasin | ≥98.0% | I≤0.2% | I≤0.3% | I≤0.5% | ≤1.0% |
40 | Fmoc-sar-huag | 77128-70-2 | Saralasin | ≥98.0% | I≤0.2% | I≤0.3% | I≤0.5% | ≤1.0% |
41 | FMOC-Tyr (SO3NA) -OH.h.hmo | 106864-37-3 | Siab dawb | ≥98.0% | I≤0.2% | I≤0.3% | I≤0.5% | ≤1.0% |
42 | FMOC-D-ASP (OTBU) -O | 112883-39-3 | Daptomycin | ≥98.5% | I≤0.2% | I≤0.3% | I≤0.5% | ≤1.0% |
43 | Ac-ser (tbu) -oh | 77285-09-7 | Afamelanotide | ≥99.0% | I≤0.2% | I≤0.3% | I≤0.3% | ≤1.0% |
44 | Boc-homocys (trt) -oh | 201419-16-1 | Tsis dim | ≥98.0% | I≤0.2% | I≤0.3% | I≤0.5% | ≤1.0% |
45 | Fmoc-homocys (trt) -o | 167015-23-8 | Tsis dim | ≥98.0% | I≤0.2% | I≤0.3% | I≤0.5% | ≤1.0% |
46 | FMOC-DAB-AH | 161420-87-7 | Nab venom | ≥99.0% | I≤0.2% | I≤0.3% | I≤0.3% | ≤1.0% |
* Max1 = Max tsis paub meej huv
Lwm yam qhia:
- acetic acid: ≤0.02% (tag nrho cov khoom lag luam)
- Ethyl Acetate: ≤0.5% (tag nrho cov khoom)
- Cawv (Curn0.5% (Txhua Yam Khoom)
- Max tsis paub txog impurity: FMOC-TRP (boc) -oh (143824-78-6) ≤0.3%; Lwm tus I≤0.2%